Literature DB >> 23304225

Application of complementary and alternative medicine on neurodegenerative disorders: current status and future prospects.

Paul Siu-Po Ip1, Karl Wah-Keung Tsim, Kelvin Chan, Rudolf Bauer.   

Abstract

Entities:  

Year:  2012        PMID： 23304225      PMCID： PMC3524983          DOI： 10.1155/2012/930908

Source DB:  PubMed          Journal:  Evid Based Complement Alternat Med        ISSN： 1741-427X            Impact factor:   2.629


× No keyword cloud information.
  5 in total

1.  Subchronic exposure to leachate activates key markers linked with neurological disorder in Wistar male rat.

Authors:  J K Akintunde; G Oboh
Journal:  Environ Sci Pollut Res Int       Date:  2015-09-11       Impact factor: 4.223

Review 2.  Advances in neuroprotective ingredients of medicinal herbs by using cellular and animal models of Parkinson's disease.

Authors:  Sandeep Vasant More; Hemant Kumar; Seong Mook Kang; Soo-Yeol Song; Kippeum Lee; Dong-Kug Choi
Journal:  Evid Based Complement Alternat Med       Date:  2013-09-01       Impact factor: 2.629

Review 3.  The safety and efficacy of using moxibustion and or acupuncture for cancer-related insomnia: a systematic review and meta-analysis of randomised controlled trials.

Authors:  Carol Chunfeng Wang; Ellen Yichun Han; Mark Jenkins; Xuepei Hong; Shuqin Pang; Lisa Whitehead; Deborah L Kirk; Anne Williams
Journal:  Palliat Care Soc Pract       Date:  2022-01-10

4.  Naringin and Rutin Alleviates Episodic Memory Deficits in Two Differentially Challenged Object Recognition Tasks.

Authors:  Grandhi Venkata Ramalingayya; Madhavan Nampoothiri; Pawan G Nayak; Anoop Kishore; Rekha R Shenoy; Chamallamudi Mallikarjuna Rao; Krishnadas Nandakumar
Journal:  Pharmacogn Mag       Date:  2016-01       Impact factor: 1.085

5.  A Review of the Clinical Evidence for Complementary and Alternative Medicine in Huntington's Disease.

Authors:  Margaret Yu; Danny Bega
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2019-08-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.